Leen Kawas serves as Executive at Eiger BioPharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Leen Kawas has executed 2 insider transactions totaling $6.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 31, 2023 involved purchasing 12,345 shares valued at $3.2K.
Leen Kawas currently holds 4,391,432 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leen Kawas has been a net buyer of EIGR stock. They have purchased $6.3K and sold $0 worth of shares.
Leen Kawas's most recent insider trade was on Oct 31, 2023, when they purchased 12,345 shares at $0.26 per share.
Get notified when new Form 4 filings are submitted
| $0.26 |
| Discretionary |